Tagged: capital cell

October 3, 2018 @ 11:35 am By JD Alois  |  

Arcis Biotechnology is crowdfunding on Capital Cell now having already raised £1.25 million. The company is hoping to raise £1.75 million at a pre-money valuation of £18.2 million. Capital Cell “endorses” this company and has posted the following statement: “Arcis’ technology allows the extraction of… Read More

May 22, 2018 @ 3:47 pm By Erin Hobey  |  

Capital Cell recently launched a new self-funding fundraising round to create the first ICO marketplace for health via Blockchain. Seeking to raise €700,000, the Barcelona-based platform has already secured over €882,400 from more than 178 investors. The platform was pre-valued at €5,550,000. “We launched the funding round… Read More

January 4, 2018 @ 2:12 pm By Erin Hobey  |  

Cebiotex, a CataloniaBio member, has launched a new crowdequity campaign to raise €650,000 through CapitalCell in order to ensure its first drug, CEB-01 for post-op treatment of soft-tissue sarcomas, reaches pediatric oncology. The campaign is part of a larger €1.6-million round of funding; since launching, the… Read More

September 22, 2017 @ 9:20 am By Samantha Hurst  |  

Capital Cell, a crowdfunding platform dedicated to life sciences, announced this week it is officially opening its portal to UK investors. The first four investment opportunities now live on the platform. As previously reported, Capital Cell was founded by Daniel Oliver and based in Barcelona, is the first… Read More

June 1, 2017 @ 5:14 pm By JD Alois  |  

Born in Spain and shipped to the UK, Capital Cell has officially launched in Great Britain. Capital Cell , founded by Daniel Oliver and based in Barcelona, is the first European equity crowdfunding platform for Biotech projects.  After several successful years of investment crowdfunding in… Read More

January 3, 2017 @ 2:58 pm By Samantha Hurst  |  

Era7 Bioinformatics, a Spanish company that focuses on the revolution of the Microbiome and providing new solutions to address the problem of antibiotic resistance, announced this week it closed its Capital Cell campaign, which raised nearly €600,000 in funding. As previously reported, Era7 Bioinformatics was… Read More

July 29, 2016 @ 8:46 am By JD Alois  |  

Capital Cell, an investment crowdfunding platform that describes itself as the first European crowdfunding platform for biotech projects, has recieved regulatory approval from the Comisión Nacional del Mercado de Valores (CNMV).  According to a statement on their site, after ten months of audits, interviews and… Read More

February 23, 2016 @ 7:10 am By Erin Hobey  |  

Capital Cell, the first European equity crowdfunding platform specializing in biotech and life sciences startups and companies, has successfully linked with entrepreneurs and investors on their most recent self-funding round. To date the Barcelona-based equity crowdfunding platform founded in 2015  by CEO Daniel Oliver, who also serves as the president of Asociación Española… Read More

February 2, 2016 @ 6:13 am By Erin Hobey  |  

Capital Cell is the first European equity crowdfunding platform specializing in biotech and  life sciences startups and companies.  Capital Cell links with entrepreneurs seeking funding with investors who want to invest their money in projects with a high growth potential. To date the Barcelona-based equity crowdfunding platform founded in 2015… Read More

May 21, 2015 @ 4:10 pm By Erin Hobey  |  

The Catalan company ZeClinics, supported by the University Pompeu Fabra of Barcelona and and Barcelona Biomedicine Research Park (PRBB) reached its crowdfunding campaign goal  on Capital Cell,  a campaign that set the record for the the year’s largest biotech crowdfunding investment in Spain.  The company is prevalued at 1M€.  After 88… Read More